Format

Send to

Choose Destination
Cancer Prev Res (Phila). 2016 Feb;9(2):125-7. doi: 10.1158/1940-6207.CAPR-15-0432. Epub 2015 Dec 29.

When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial Design.

Author information

1
Departments of Dermatology and Translational Molecular Pathology, Divisions of Internal Medicine and Pathology, MD Anderson Cancer Center, Houston, Texas. kytsai@mdanderson.org.
2
Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, Texas.
PMID:
26714773
DOI:
10.1158/1940-6207.CAPR-15-0432
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center